Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
Coherus BioSciences, Nasdaq: CHRS, will present at the 39th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Coherus BioSciences, Nasdaq: CHRS, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 10:50 a.m. EST / 7:50 a.m. PST. The audio presentation can be accessed on the company's investor website. Coherus specializes in commercial-stage biosimilars aimed at enhancing access to impactful therapeutics while delivering healthcare savings.
Details
News Market Reaction – CHRS
The recorded move for CHRS in the trading session of this news was +2.08%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m. EST / 7:50 a.m. PST.
The audio portion of the Company presentation will be available on the investors page of the Coherus BioSciences website at https://investors.coherus.com.
About Coherus BioSciences, Inc.
Coherus is a leading commercial-stage biosimilar company dedicated to expanding access to high-quality therapeutics that can have a major impact on patients’ lives and to delivering significant savings to the health care system. For additional information, please visit www.coherus.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.